INS and myeloid sarcoma: UA causes reduction in endothelial nitric oxide (NO) level, the key mediator of insulin action, which in turn disturbs blood flow and glucose uptake in skeletal muscles leading to insulin resistance and development of metabolic syndrome (MS) [8].